Clinical Trial Update: An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects [Phase 3]

View source ↗

Summary

An extension phase 3 trial of JR-141 to assess long-term safety and efficacy in Mucopolysaccharidosis type II (Hunter syndrome) patients, with ongoing enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Ii

Drugs mentioned

• JR-141

Snippet

Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis II | Phase 3 | Status: ENROLLING_BY_INVITATION